BridgeMD
New treatment option for Lung Cancer
Official title Investigation of the Effects of Functional Inspiratory Muscle Training in Patients With Lung Cancer
ClinicalTrials.gov ID: NCT06245343
What this study is testing
- What it's testing
- Patients' pulmonary functions and diffusion capacity worsen following lung cancer surgery. Diaphragmatic activity and lung compliance decrease due to surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients aged 18-80 years with lung cancer
- Patients who have undergone surgical treatment (wedge resection, segmentectomy, lobectomy, bilobectomy) for lung cancer
- Lung cancer treatment completed, in remission and under follow-up
You likely can't join if
- According to the American Association of Sports Medicine (ACSM) with absolute and relative contraindications to exercise tests
- Patients who are having comorbidities such as uncontrolled hypertension, diabetes mellitus, heart failure or atrial fibrillation
- Patients who are having acute infection during evaluation
- Patients who are having orthopedic, neurological, psychological, etc. problems that limit evaluations
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Çankaya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Çankaya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.